Skip to content

Released May 6, 2019, after the close

10-Q filed May 6, 2019, 36 days after period end · 0001564590-19-015990

Q1 2019 · 10-Q
Revenue$109.11M+0.4% vs Q1 2018−9.9% vs Q4 2018
Net Income$897.00K−82.8% vs Q1 2018−89.9% vs Q4 2018
EPS Diluted$0.05−81.5% vs Q1 2018−89.1% vs Q4 2018
Gross Profit$85,404,000+1.0%
Operating Income-$4,448,000N/M
Operating Cash Flow-$1,039,000N/M
Free Cash Flowderived-$5,682,000N/M
Margins · derived
Gross margin78.3%+0.5 pt vs Q1 2018
Operating margin-4.1%−11.3 pt vs Q1 2018
Net margin0.8%−4.0 pt vs Q1 2018

What the release said

The release

Same quarter

MetricQ1 2019Q1 2018Q1 2017Q1 2016
Revenue$109.11M$108.71M$102.74M$98.68M
Net Income$897.00K$5.23M-$2.65M$3.84M
EPS Diluted$0.05$0.27-$0.15$0.20

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR